SDHD Gene Cowden syndrome type 3 Genetic Test
At DNA Labs UAE, we offer the SDHD Gene Cowden syndrome type 3 Genetic Test for individuals who may be at risk for this rare genetic disorder. This diagnostic test analyzes the SDHD gene for mutations associated with Cowden syndrome type 3.
Components
- Test Name: SDHD Gene Cowden syndrome type 3 Genetic Test
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test type: Cancer
- Doctor: Oncologist
- Test Department: Genetics
Pre Test Information
Prior to undergoing the SDHD Gene Cowden syndrome type 3 NGS Genetic DNA Test, it is important for the patient to provide their clinical history. A genetic counseling session may also be conducted to draw a pedigree chart of family members affected by SDHD Gene Cowden syndrome type 3.
Test Details
The SDHD gene Cowden syndrome type 3 NGS genetic test is a diagnostic test that analyzes the SDHD gene for mutations associated with Cowden syndrome type 3. Cowden syndrome is a rare genetic disorder characterized by multiple noncancerous tumor-like growths called hamartomas, as well as an increased risk of developing certain types of cancer, including breast, thyroid, and uterine cancer.
The NGS (next-generation sequencing) genetic test utilizes advanced sequencing technology to analyze the DNA sequence of the SDHD gene and identify any mutations or variants that may be present. This test is recommended for individuals with a family history of Cowden syndrome or related conditions, as well as those who exhibit symptoms suggestive of the disorder.
By undergoing this genetic test, individuals can confirm a diagnosis of Cowden syndrome type 3 and obtain crucial information for managing the condition. This includes surveillance for cancer and other associated health risks.
It is important to note that this test specifically focuses on the SDHD gene and may not detect mutations in other genes associated with Cowden syndrome or related conditions. Therefore, additional genetic testing may be necessary to fully evaluate the risk of developing Cowden syndrome or related disorders.
Test Name | SDHD Gene Cowden syndrome type 3 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Cancer |
Doctor | Oncologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for SDHD Gene Cowden syndrome type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SDHD Gene Cowden syndrome type 3 NGS Genetic DNA Test gene SDHD |
Test Details |
SDHD gene Cowden syndrome type 3 NGS genetic test is a diagnostic test that analyzes the SDHD gene for mutations associated with Cowden syndrome type 3. Cowden syndrome is a rare genetic disorder characterized by multiple noncancerous tumor-like growths called hamartomas, as well as an increased risk of developing certain types of cancer, including breast, thyroid, and uterine cancer. The SDHD gene is one of the genes associated with Cowden syndrome, and mutations in this gene can increase the risk of developing the condition. The NGS (next-generation sequencing) genetic test uses advanced sequencing technology to analyze the DNA sequence of the SDHD gene and identify any mutations or variants that may be present. This genetic test is typically recommended for individuals who have a family history of Cowden syndrome or related conditions, as well as those who have symptoms suggestive of the disorder. The test can help confirm a diagnosis of Cowden syndrome type 3 and provide important information for managing the condition, including surveillance for cancer and other associated health risks. It is important to note that this test specifically focuses on the SDHD gene and may not detect mutations in other genes associated with Cowden syndrome or other related conditions. Therefore, additional genetic testing may be necessary to fully evaluate the risk of developing Cowden syndrome or related disorders. |